Evidence map›Paper›PMID 37682828›Full record

ArticlePloS one2023

A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol.

Douglas H Fernald, Donald E Nease, John M Westfall, Bethany M Kwan, L Miriam Dickinson, Ben Sofie, Cory Lutgen, Jennifer K Carroll, David Wolff, Lori Heeren and 2 more

Erratum issuedOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Induction of Medication for Opioid Use Disorder in Primary Care.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Douglas H FernaldDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0001-7392-0113
Donald E NeaseDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
John M WestfallDepartment of Family Medicine, University of Colorado School of Medicine (retired), Aurora, Colorado, United States of America.
Bethany M KwanDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
L Miriam DickinsonDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Ben SofieDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Cory LutgenAmerican Academy of Family Physicians, National Research Network, Leawood, Kansas, United States of America.ORCID 0000-0002-6589-4557
Jennifer K CarrollDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
David WolffHOMER Community Advisory Council, Aurora, Colorado, United States of America.
Lori HeerenHOMER Community Advisory Council, Aurora, Colorado, United States of America.
Maret FelzienHOMER Community Advisory Council, Aurora, Colorado, United States of America.
Linda ZittlemanDepartment of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
University of Colorado Denver · USAmerican Academy of Family Physicians · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
NCATS NIH HHS UL1 TR002535
6 · The paper itself

Abstract

Opioid use disorder (OUD) represents a public health crisis in the United States. Medication for opioid use disorder (MOUD) with buprenorphine in primary care is a proven OUD treatment strategy. MOUD induction is when patients begin withdrawal and receive the first doses of buprenorphine. Differences between induction methods might influence short-term stabilization, long-term maintenance, and quality of life. This paper describes the protocol for a study designed to: (1) compare short-term stabilization and long-term maintenance treatment engagement in MOUD in patients receiving office, home, or telehealth induction and (2) identify clinically-relevant practice and patient characteristics associated with successful long-term treatment. The study design is a randomized, parallel group, pragmatic comparative effectiveness trial of three care models of MOUD induction in 100 primary care practices in the United States. Eligible patients are at least 16 years old, have been identified by their clinician as having opioid dependence and would benefit from MOUD. Patients will be randomized to one of three induction comparators: office, home, or telehealth induction. Primary outcomes are buprenorphine medication-taking and illicit opioid use at 30, 90, and 270 days post-induction. Secondary outcomes include quality of life and potential mediators of treatment maintenance (intentions, planning, automaticity). Potential moderators include social determinants of health, substance use history and appeal, and executive function. An intent to treat analysis will assess effects of the interventions on long-term treatment, using general/generalized linear mixed models, adjusted for covariates, for the outcomes analysis. Analysis includes practice- and patient-level random effects for hierarchical/longitudinal data. No large-scale, randomized comparative effectiveness research has compared home induction to office or telehealth MOUD induction on long-term outcomes for patients with OUD seen in primary care settings. The results of this study will offer primary care providers evidence and guidance in selecting the most beneficial induction method(s) for specific patients.

Indexed as

BuprenorphineOpioid-Related DisordersAdolescentHumansPragmatic Clinical Trials as TopicPrimary Health CareQuality of LifeRandomized Controlled Trials as TopicResearch DesignBuprenorphine

Identifiers

PMID37682828
PMCPMC10490863
OpenAlexW4386558821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.